Genes whose expression was correlated with differential methylation in SETD2 cases show an enrichment for processes such as neoplasm invasiveness, in particular kidney neoplasm, which suggests that SETD2 mutations may be involved in cancer aggressiveness through DNA methylation. This evidence concerns the gene SETD2 and cancer.